Autologous Transplantation for Chronic Myelogenous Leukemia Using Retrovirally Marked Peripheral Blood Progenitor Cells Obtained After In Vivo Cyclophosphamide/G-CSF Priming.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Busulfan; Cyclophosphamide; Interferon alpha
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 29 Nov 2017 Biomarkers information updated
- 16 Dec 2008 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
- 16 Sep 2005 New trial record.